United States: Life Sciences, Biotechnology & Nanotechnology

The US Department of Defense has significantly expanded its Section 1260H List of Chinese Military Companies, adding 65 entities spanning technology, electric vehicles, biotechnology, and manufacturing sectors.

On June 3, 2026, the U.S. Food and Drug Administration issued a new draft guidance titled Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities — Questions and Answers (the 2026 Draft Payor Guidance).

The US Departments of Health and Human Services, Labor, and the Treasury have issued a final rule updating the federal independent dispute resolution process under the No Surprises Act, addressing the substantial...

The Department of Health and Human Services has proposed significant updates to both the HIPAA Security Rule and Privacy Rule, marking the first major overhaul in years. These proposed rulemakings introduce key policy changes that will impact healthcare organizations, business associates, and covered entities across the industry. Understanding the rationale behind these modifications and their potential implementation timeline is crucial for stakeholders preparing for compliance.

Explore the latest developments in biosimilar approvals, regulatory updates, and strategic acquisitions shaping the pharmaceutical landscape.

This article compiles recent developments in the biosimilar pharmaceutical industry, covering regulatory submissions, market launches, licensing agreements, and legal proceedings across multiple therapeutic areas.

The U.S. healthcare and life sciences industry faces mounting pressure from affordability concerns and regulatory challenges that threaten its traditional business model. AlixPartners' inaugural...

The EPA has issued a fact-check statement addressing false claims circulating online about recent authorizations for genetically engineered mosquito releases in the United States.

Microbial crop products are revolutionizing agriculture by reducing chemical dependency, but their complexity demands robust patent protection. European patent practice offers unique opportunities...